23 Einträge gefunden

1. No need for NMDA receptor antibody screening in neurologically asymptomatic patients with ovarian teratomas

   1. Trillsch, Fabian
   2. Eichhorn, Peter
   3. Oliveira-Ferrer, Leticia
   4. Kuempfel, Tania
   5. Burges, Alexander
   6. Mahner, Sven
   7. Havla, Joachim

   2018 - Forschungsinformationssystem des UKE
2. Loss of BRCA1 promotor hypermethylation in recurrent high-grade ovarian cancer

   1. Prieske, Katharina
   2. Prieske, Stefan
   3. Joosse, Simon A
   4. Trillsch, Fabian
   5. Grimm, Donata
   6. Burandt, Eike
   7. Mahner, Sven

   2017 - Forschungsinformationssystem des UKE
3. VEGF-C expression attributes the risk for lymphatic metastases to ovarian cancer patients

   1. Kuerti, Sascha
   2. Oliveira-Ferrer, Leticia
   3. Milde-Langosch, Karin
   4. Schmalfeldt, Barbara
   5. Legler, Karen
   6. Woelber, Linn
   7. Prieske, Katharina

   2017 - Forschungsinformationssystem des UKE
4. E-Cadherin fragments as potential mediators for peritoneal metastasis in advanced epithelial ovarian cancer

   1. Trillsch, Fabian
   2. Kuerti, Sascha
   3. zu Eulenburg, Christine
   4. Burandt, Eike
   5. Woelber, Linn
   6. Prieske, Katharina
   7. Eylmann, Kathrin

   2016 - Forschungsinformationssystem des UKE
5. Patterns of distant metastases in vulvar cancer

   1. Prieske, Katharina
   2. Haeringer, Nicole
   3. Grimm, Donata
   4. Trillsch, Fabian
   5. Eulenburg, Christine
   6. Burandt, Eike
   7. Schmalfeldt, Barbara

   2016 - Forschungsinformationssystem des UKE
6. The Risk of Contralateral Non-sentinel Metastasis in Patients with Primary Vulvar Cancer and Unilaterally Positive Sentinel Node

   1. Woelber, Linn
   2. Eulenburg, Christine
   3. Grimm, Donata
   4. Trillsch, Fabian
   5. Bohlmann, Inga
   6. Burandt, Eike
   7. Dieckmann, Jan

   2016 - Forschungsinformationssystem des UKE
7. Cadherin-11 mRNA- und Protein-Expression in Ovarialtumoren unterschiedlicher Malignität: kein Hinweis auf eine onkogene oder tumorsupprimierende Funktion., Cadherin-11 mRNA and protein expression in ovarian tumors of different malignancy: No evidence of oncogenic or tumor-suppressive function.

   1. von Bülow, Charlotte
   2. Oliveira Ferrer, Leticia
   3. Löning, Thomas
   4. Trillsch, Fabian
   5. Mahner, Sven
   6. Milde-Langosch, Karin

   2015 - Forschungsinformationssystem des UKE
8. Quality of life and sexual function in patients with borderline tumors of the ovary. A substudy of the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) study group ROBOT study

   1. Farthmann, Juliane
   2. Hasenburg, Annette
   3. Weil, Meike
   4. Fotopoulou, Christina
   5. Ewald-Riegler, Nina
   6. du Bois, Oya
   7. Trillsch, Fabian

   2015 - Forschungsinformationssystem des UKE
9. Diagnostic and prognostic potential of serum miR-7, miR-16, miR-25, miR-93, miR-182, miR-376a and miR-429 in ovarian cancer patients

   1. Meng, Xiaodan
   2. Joosse, Simon A
   3. Müller, Volkmar
   4. Trillsch, Fabian
   5. Milde-Langosch, Karin
   6. Mahner, Sven
   7. Geffken, Maria

   2015 - Forschungsinformationssystem des UKE
10. Sexual activity and function after surgical treatment in patients with (pre)invasive vulvar lesions

    1. Grimm, Donata
    2. zu Eulenburg, Christine
    3. Brummer, Oliver
    4. Schliedermann, Anna-Katharina
    5. Trillsch, Fabian
    6. Prieske, Katharina
    7. Gieseking, Friederike

    2015 - Forschungsinformationssystem des UKE
11. Systemic treatment of vulvar cancer

    1. Mahner, Sven
    2. Prieske, Katharina
    3. Grimm, Donata
    4. Trillsch, Fabian
    5. Prieske, Stefan
    6. von Amsberg, Gunhild
    7. Petersen, Cordula

    2015 - Forschungsinformationssystem des UKE
12. Sexual Activity and Function in Patients With Gynecological Malignancies After Completed Treatment

    1. Grimm, Donata
    2. Hasenburg, Annette
    3. zu Eulenburg, Christine
    4. Steinsiek, Lisa
    5. Mayer, Sebastian
    6. Eltrop, Stephanie
    7. Prieske, Katharina

    2015 - Forschungsinformationssystem des UKE
13. Beyond Bevacizumab: An Outlook to New Anti-Angiogenics for the Treatment of Ovarian Cancer

    1. Mahner, Sven
    2. Woelber, Linn
    3. Müller, Volkmar
    4. Witzel, Isabell
    5. Prieske, Katharina
    6. Grimm, Donata
    7. von Amsberg, Gunhild

    2015 - Forschungsinformationssystem des UKE - frei zugänglich
14. Clinical management of epithelial ovarian cancer during pregnancy

    1. Grimm, Donata
    2. Woelber, Linn
    3. Trillsch, Fabian
    4. Keller-v. Amsberg, Gunhild
    5. Mahner, Sven

    2014 - Forschungsinformationssystem des UKE
15. Management of patients with vulvar cancer: a perspective review according to tumour stage

    1. Woelber, Linn
    2. Trillsch, Fabian
    3. Kock, Lilli
    4. Grimm, Donata
    5. Petersen, Cordula
    6. Choschzick, Matthias
    7. Jänicke, Fritz

    2013 - Forschungsinformationssystem des UKE - frei zugänglich
16. The prognostic significance of Jun transcription factors in ovarian cancer

    1. Eckhoff, Kerstin
    2. Flurschütz, Roland
    3. Trillsch, Fabian
    4. Mahner, Sven
    5. Jänicke, Fritz
    6. Milde-Langosch, Karin

    2013 - Forschungsinformationssystem des UKE
17. Adjuvant therapy in node-positive vulvar cancer

    1. Mahner, Sven
    2. Trillsch, Fabian
    3. Kock, Lilli
    4. Rohsbach, Donata
    5. Petersen, Cordula
    6. Krüll, Andreas
    7. Harter, Philipp

    2013 - Forschungsinformationssystem des UKE
18. Value of tertiary cytoreductive surgery in epithelial ovarian cancer: an international multicenter evaluation.

    1. Fotopoulou, Christina
    2. Zang, Rongyu
    3. Gultekin, Murat
    4. Cibula, David
    5. Ayhan, Ali
    6. Liu, Dongli
    7. Richter, Rolf

    2013 - Forschungsinformationssystem des UKE
19. Surgical management and perioperative morbidity of patients with primary borderline ovarian tumor (BOT)

    1. Trillsch, Fabian
    2. Ruetzel, Jan David
    3. Herwig, Uwe
    4. Doerste, Ulrike
    5. Woelber, Linn
    6. Grimm, Donata
    7. Choschzick, Matthias

    2013 - Forschungsinformationssystem des UKE - frei zugänglich
20. Platelet-derived growth factor receptor beta serum concentrations during first-line therapy in ovarian cancer

    1. Mathey, Sabrina
    2. Graeser, Monika Karla
    3. Zu Eulenburg, Christine
    4. Woelber, Linn
    5. Trillsch, Fabian
    6. Jänicke, Fritz
    7. Müller, Volkmar

    2013 - Forschungsinformationssystem des UKE